Skip to search formSkip to main contentSkip to account menu

MenACWY-CRM vaccine

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Meningococcal vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.
2016
2016
Immunogenicity of MenACWY-CRM in Korean Military Recruits: Influence of Tetanus-Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY-CRM
The quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) has been introduced for military recruits in Korea since 2012… 
2016
2016
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label Trial
Background: The quadrivalent meningococcal glycoconjugate vaccine MenACWY-CRM is licensed for children from 2 months of age as a… 
2015
2015
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination.
2014
2014
Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age
Background: Infants are at the highest risk for meningococcal disease and a broadly protective and safe vaccine is an unmet need… 
2014
2014
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b…
Review
2013
Review
2013
Use of MenACWY-CRM in adolescents in the United States.
Highly Cited
2012
Highly Cited
2012
Safety and Immunogenicity of a Novel Quadrivalent Meningococcal CRM-conjugate Vaccine Given Concomitantly With Routine Vaccinations in Infants
Background: In phase II studies, MenACWY-CRM elicited robust immunologic responses in young infants. We now present results from… 
2012
2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
2010
2010
Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined…
ABSTRACT This study evaluated the safety, tolerability, and immunogenicity of an investigational quadrivalent meningococcal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)